NMT1 and pancreatic neoplasm: Here we demonstrated that tris DBA, an inhibitor of NMT1 is effective at reducing growth and metastasis of pancreatic cancer in vivo, indicating that NMT1 may be a novel therapeutic target in pancreatic cancer.